Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Hair loss requires customized treatments based on its various causes and types.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Mind-body techniques and a team approach can help manage skin conditions linked to psychological factors.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

PP-PTKL may help treat hair greying, but more testing is needed.

Personalized medicine and new technologies offer promising strategies for better skin disease treatments.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Oral Apremilast effectively treats alopecia areata in most patients.

Stress can trigger and worsen vitiligo.

Betamethasone oral mini-pulse therapy showed good or fair results in treating lichen planus.

The Nd:YAG laser is a successful and safe way to treat ingrown and pincer nails.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

PRP therapy is effective and safe for skin conditions like wound healing and hair loss.